Bioventix PLC (LON:BVXP – Get Free Report) insider Peter John Harrison bought 875 shares of Bioventix stock in a transaction dated Tuesday, November 4th. The stock was purchased at an average price of GBX 2,220 per share, with a total value of £19,425.
Bioventix Stock Performance
BVXP stock opened at GBX 2,121 on Wednesday. Bioventix PLC has a one year low of GBX 1,750 and a one year high of GBX 4,000. The stock has a market capitalization of £110.82 million, a PE ratio of 14.32 and a beta of 0.35. The company has a fifty day moving average of GBX 2,364.17 and a 200-day moving average of GBX 2,571.54.
Bioventix (LON:BVXP – Get Free Report) last released its earnings results on Monday, October 27th. The biotechnology company reported GBX 145.27 EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. Equities analysts forecast that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Further Reading
- Five stocks we like better than Bioventix
- With Risk Tolerance, One Size Does Not Fit All
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- What is Insider Trading? What You Can Learn from Insider Trading
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
